Next to the in vitro analysis, the in vivo anti-tumor and anti-metastatic activity of 1 and 2 was investigated in orthotopic breast and colon carcinoma-bearing mice to ensure high potency of our GnRH-III based DDSs. Here, GNRH1 is linked to colon carcinoma.